Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab

Objective: To investigate resource use and time investments of healthcare professionals, patients and their family and to compare healthcare and societal costs of one single hospital-based and one single home-based subcutaneous administration of trastuzumab in The Netherlands. Method: We conducted a bottom-up micro-costing study. Patients diagnosed with HER2+ early or metastatic breast cancer were recruited in four Dutch hospitals. For healthcare costs, data were collected on drug use, consumables, use of healthcare facilities, time of healthcare professionals, and travelling distance of the n... Mehr ...

Verfasser: Franken, M.G. (Margreet)
Kanters, T.A. (Tim)
Coenen, J.L.L.M. (Jules)
Jong, P.C. (Paul) de
Jager, A. (Agnes)
Groot, C.U.-D. (Carin Uyl-de)
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Schlagwörter: Breast cancer / Healthcare costs / Home-based / Hospital-based / Injection / Micro-costing / Netherlands / Resource use / Societal costs / Subcutaneous / Trastuzumab
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26832054
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/127232